The phantom of lactic acidosis due to metformin in patients with diabetes.
about
Use of metformin in the setting of mild-to-moderate renal insufficiencyTreatment of non-alcoholic fatty liver diseaseUse of metformin in diseases of agingMetformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the EndotheliumDiabetes in African AmericansThe obesity pandemic: where have we been and where are we going?Effect of prescribing metformin according to eGFR instead of serum creatinine level: A study based on Korean National Health and Nutrition Examination Survey (KNHANES) 2009-2014.Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes.Metformin use and mortality in ambulatory patients with diabetes and heart failure.Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy.Cardiovascular safety profile of currently available diabetic drugs.Outcome of severe lactic acidosis associated with metformin accumulation.Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review.Metformin-induced lactic acidosis: a case seriesMetformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3).History of current non-insulin medications for diabetes mellitus.Standards of medical care in diabetes--2009.Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality.Review article: Diabetes mellitus and heart failure--an overview of epidemiology and management.The role of serum lactate in the acute care setting.Metformin use among individuals at risk for type 2 diabetes.The Role of Metformin in Metformin-Associated Lactic Acidosis (MALA): Case Series and Formulation of a Model of Pathogenesis.Lactic acidosis: relationship between metformin levels, lactate concentration and mortality.The Dramatic Recovery of a Patient with Biguanide-associated Severe Lactic Acidosis Following Thiamine Supplementation.Metformin's contraindications: needed for now.The criteria for metformin-associated lactic acidosis: the quality of reporting in a large pharmacovigilance database.AERS spider: an online interactive tool to mine statistical associations in Adverse Event Reporting System.Metformin and lactic acidosis in patients with type 2 diabetes--from pride and prejudice to sense and sensibility.Provider Decisions and Patient Outcomes After Premature Metformin Discontinuation.Metformin and ageing: improving ageing outcomes beyond glycaemic control.Metformin Use in Practice: Compliance With Guidelines for Patients With Diabetes and Preserved Renal Function.Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes.Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy.
P2860
Q22241290-998D7CA4-19BF-49D3-ADD0-F634BE2BEBB5Q24655572-97A70B56-298D-4BA9-9BB5-71040E44E8ABQ26828760-C3CCC7D7-3263-4CE1-9862-DEE68E5D0D58Q26999344-6C580941-2873-4BAB-9011-06C3A320D0A9Q28394087-5B923F35-E9D1-4244-A5D9-D018269B9FF8Q30349835-1BD9BB6E-8D6D-4D12-90EF-898914DE336EQ33554434-7159CD69-87E8-490B-9CBB-32B45D8BD203Q33793434-F1C34D83-8211-4C0F-A298-E23FB1FEF42DQ34614524-E32D22AC-7B45-4C26-8B76-7AC028330CBDQ34620649-4DB3366C-3201-48D2-BE7F-227A89375B30Q34971736-01D113AC-63D1-4055-85AD-05F6D9248AECQ35561308-417D3009-76E5-4E2D-84A6-94A067F1EF46Q36240156-E8542787-2F85-470F-A62B-2C71B0E4EE22Q36316126-B7C60023-76C6-485B-9AE8-0A568C49F49AQ36709745-170E50B5-95BD-4792-A670-52A42863D7D4Q37021310-87334586-5AED-4BCA-803B-453A293141EEQ37036416-1834BC96-4B4E-495C-8F13-B39A0EA87F0EQ37102216-E40F3391-0106-4C88-91E7-B43C15CB477EQ37724505-860E5A74-AC80-43F2-8D29-5A7EF58990BBQ37771798-CF549147-2BCC-4B62-92B0-7AC581666804Q37991589-2E08FC11-7A14-4835-AF19-7CEFEE33A1C1Q38095393-8C7250D3-3A97-422D-9727-FBC3B36B7CCDQ39993479-6428C59F-FFE0-430B-8EAA-68BA14554E7BQ42314523-5E532561-4590-4D8A-AA46-0F150082C312Q42939042-FFDC13B3-719E-4F75-BD8D-B05238D60C16Q44084382-0918A2A6-1F29-46D4-B6AE-A28769877C5EQ46036399-0E3D4E23-A7F6-486C-BBEC-01CA9249E42BQ46076997-D8929640-8F1D-49FE-8D22-8894AA522D7BQ47952257-908D91CD-B229-43A9-85D4-46267383CF6AQ50431116-C7615257-CDCD-4C0D-AEAF-6664E9B7FEEAQ51806270-122FB581-FE55-43C7-AA90-99CE07C93F76Q53623499-B09784C5-DE3C-429A-AA2A-EE4DD873ADEAQ54526459-B10586F3-B2F1-45FC-A1FB-43FAF43FBF72
P2860
The phantom of lactic acidosis due to metformin in patients with diabetes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The phantom of lactic acidosis due to metformin in patients with diabetes.
@ast
The phantom of lactic acidosis due to metformin in patients with diabetes.
@en
type
label
The phantom of lactic acidosis due to metformin in patients with diabetes.
@ast
The phantom of lactic acidosis due to metformin in patients with diabetes.
@en
prefLabel
The phantom of lactic acidosis due to metformin in patients with diabetes.
@ast
The phantom of lactic acidosis due to metformin in patients with diabetes.
@en
P1433
P1476
The phantom of lactic acidosis due to metformin in patients with diabetes.
@en
P2093
Robert I Misbin
P304
P356
10.2337/DIACARE.27.7.1791
P407
P577
2004-07-01T00:00:00Z